BAM
VIVS

Brave Asset Management’s VivoSim Labs VIVS Stock Holding History

Brave Asset Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4
Closed -$8K – 439
2014
Q2 		$8K Hold
4
– – 0.01% 385
2014
Q1 		$8K Buy
+4
New +$9.29K 0.01% 374

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CNB
City National Bank Beverly Hills, California $11.6B AUM 3.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Brave Asset Management's VIVS Position: Q3 2014 in Review

Brave Asset Management sold out of VivoSim Labs (VIVS) in Q3 2014, closing a stake of 4 shares — an estimated $8K sold.

Brave Asset Management first reported a position in VIVS in Q1 2014 and held it in 2 quarters. The position peaked at $8K in Q2 2014. 100 funds tracked by Wall St. Rank hold VIVS as of Q3 2014.

  • Brave Asset Management reported no remaining VivoSim Labs position as of Q3 2014 after selling out during the quarter.
  • Brave Asset Management sold 4 VivoSim Labs shares in Q3 2014, an estimated $8K.
  • Brave Asset Management first reported a position in VivoSim Labs in Q1 2014 and held it in 2 quarters.
  • Brave Asset Management's VivoSim Labs position peaked at $8K in Q2 2014.
  • 100 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2014.

Based on Brave Asset Management's 13F filing for Q3 2014, filed 6 Nov 2014.